Position Overview

Bicara Therapeutics is seeking a Director, Commercial Data, Insights & Analytics to build and lead the foundational commercial analytics and insights capability as we advance toward our first commercial launch in head and neck cancer. Reporting to the Vice President, Commercial Excellence, Operations & Insights, this individual will help establish the data infrastructure, market research program, forecasting models, and KPI frameworks that will guide our commercial strategy from pre-launch through and beyond launch day.

This is a high-impact, highly visible role that partners closely with Commercial, Medical, Market Access, Finance, and Business Development leadership. The Director will serve as the primary thought partner on market intelligence, performance analytics, and commercial forecasting, translating complex data into clear, decision-ready recommendations. This individual will need to be comfortable operating as a hands-on contributor in a lean, pre-commercial environment while building toward a scalable analytics function.

What Success Looks Like:

• 6 months: establish data foundation and insights programs

• 12 months: deliver forecast model and KPI frameworks

• By launch: fully integrated data and reporting environment

This role is based in our Boston office and follows a hybrid schedule, with three in-office days each week.

Responsibilities

• Commercial Data Strategy & Infrastructure

• Define and build the commercial data foundation ahead of launch, including selection, onboarding, and governance of key data sources

• Establish data standards, quality controls, and a source-of-truth reporting environment

• Define business requirements for data integration and reporting infrastructure

• Partner with Commercial Operations and IT on CRM and data capture design

• Manage external data vendors and partners

• Analytics, Commercial Strategy & Launch Performance Reporting

• Serve as a strategic analytics partner to commercial leadership

• Develop and validate commercial models and assumptions

• Support strategy with data-driven analyses

• Conduct field force sizing and deployment analyses

• Build KPI frameworks and dashboards

• Develop patient journey analytics

• Create executive-ready reporting

• Establish early signal detection frameworks

• Provide integrated commercial performance insights

• Market Research & Insights

• Define primary market research agenda

• Integrate and translate research findings into strategy

• Develop understanding of patient and HCP experience

• Partner with Medical Affairs on insights and evidence

• Commercial Forecasting

• Support forecasting processes and models

• Maintain data inputs for forecast assumptions

• Partner with Finance on planning and reporting

• Support Business Development with analytics and sizing

• Cross-Functional Partnership

• Partner across commercial, medical, finance, and clinical teams

• Support BD and launch readiness efforts

Qualifications

• Bachelor's degree required; advanced degree preferred

• 10+ years’ experience in biopharma analytics or related field

• Oncology experience required

• Experience building analytics capabilities

• Strong forecasting and modeling skills

• Experience with healthcare data sources and tools

• Strong communication and influencing skills

• Ability to travel up to 15-20%.

Company Overview

Bicara Therapeutics is a clinical-stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, we've built a global team of over 100 employees headquartered in Boston, with a clear focus on advancing our lead asset, ficerafusp alfa, or FICERA - a potentially first-in-class bifunctional EGFR-directed antibody combined with a TGF-β ligand trap. Our innovative approach combines tumor-targeting with tumor modulation, where one arm localizes to the tumor while the other serves as a modulator, designed to deliver superior efficacy, improved safety, and enhanced durability directly at the tumor site. FICERA specifically addresses a key challenge in solid tumor treatment by enabling immune cell penetration into tumors, reducing fibrosis and immunosuppression while reversing TGF-β-driven resistance mechanisms - ultimately designed to drive the deep, durable responses that may translate into better outcomes and survival for patients. For more information, please visit www.bicara.com.

Here at Bicara, we believe in building diverse teams and cultivating a culture where all voices are included. We encourage people from all backgrounds to apply.

Bicara Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.